1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : SPECIALTY PHARMACEUTICALS
  4. ARGEN X SE - ADR
Argen X SE - ADR XNAS: ARGX

Argen X SE (ADR) Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases. The company's lead product, Vyvgart (efgartigimod), was approved by the FDA in December 2021 for the treatment of generalized mya...

Read More
766.92 -4.61 (-0.60%)
50.36% Gain from 52W Low
464.7K
XNAS Volume

XNAS 27 Feb, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Argen X SE (ADR) is on 02 Mar 2026 for the purpose of TD Cowen 46(th) Annual Healthcare Conference See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
41.7 / 100
Momentum Score
Technically Neutral
45.0 / 100
Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM
Analyst Price Target
1,034
1Yr Price target upside is 35%
22 analysts

10

S

9

W

1

O

3

T

SWOT Analysis

Argen X SE (ADR) Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..